TelyRx Holdings Appoints Co-Founder Benjamin Atkins as Interim CEO
TelyRx Holdings (TELY) has announced a leadership transition, appointing co-founder and board member Benjamin Atkins as interim CEO and President. The appointment is effective November 12, following the decision by outgoing CEO Vanessa Slowey to step down to pursue other commitments. The company's board of directors has initiated a search for a permanent successor. Atkins, who succeeds Slowey, is expected to leverage his deep institutional knowledge and experience in healthcare access expansion to lead the company during this transitional period.
Tickers: $TELY
Topics: CEO Appointment Leadership Change Management Transition